Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Adjunctive Cilostazol According to CYP2C19 Polymorphism: Prospective, Randomized, Single-Center Trial:

NCT00891670 is registered in ClinicalTrials.gov with Gyeongsang National University Hospital as lead sponsor.

NCT NCT00891670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00891670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Adjunctive Cilostazol According to CYP2C19 Polymorphism: Prospective, Randomized, Single-Center Trial:
Lead sponsor
Gyeongsang National University Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2009
Completion date
July 31, 2009
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery stenosis, high post-treatment platelet reactivity, late platelet aggregation, maximal platelet aggregation